TACE + Sorafenib May Change Standard in HCC - If Overall Survival Data is Positive then Standard of Care Will Change

TACE + Sorafenib May Change Standard in HCC - If Overall Survival Data is Positive then Standard of Care Will Change

238 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Masatoshi Kudo, MD from Kindai University, Japan discusses TACE + Sorafenib may change standard in HCC and if overall survival data is positive then standard of care will change at the 2018 Gastrointestinal Cancers Symposium.
Up Next Autoplay